Drug Trial Radar · NCT07141329
SPN-817 Open-Label Extension Study in Adults With Focal Onset Seizures
Last checked: Nov 19, 2026Latest source record: Oct 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Enrolling by invitation
Enrollment
100
Planned (sponsor's estimate)
Start
Jul 30, 2025
Primary completion
Dec 31, 2027
Study completion Dec 31, 2027
Sponsor
- Lead sponsor
- Supernus Pharmaceuticals, Inc.Industry
- Sponsor type
- Industry
- First posted
- Aug 26, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase 2b open-label extension study to evaluate the long-term safety and efficacy of SPN-817.
Conditions
- Focal Onset Seizures
Interventions
SPN-817Drug
SPN-817 starting at 0.25 mg bid up to 4.00 mg bid
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of treatment-emergent adverse eventsTime frame: Week 1-Week 52
Locations
8 sites in 2 countries. Site status is shown where the registry gives one.
Center for Neurosciences
Tucson, Arizona
Focus Clinical Research
West Hills, California
Ilumina Medical Research
Kissimmee, Florida
Medsol Clinical Research Center
Port Charlotte, Florida
University of Rochester Medical Center
Rochester, New York
Asheville Neurology Specialists
Asheville, North Carolina
Thomas Jefferson University
Philadelphia, Pennsylvania
The Alfred Hospital
Melbourne, Victoria, Australia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.